Vendor scorecard

Asan Medical Center

76/100
Routable
South Korea · International hospital (Seoul · Songpa-gu) · Korea's largest tertiary hospital, Newsweek World #3 Endocrinology 2025

Asan Medical Center scored 76/100 on Panya's 11-signal vendor rubric. Each signal is scored 0 to 100, the methodology is public, and our affiliate posture is flat-fee — never pay-to-rank. Below is the full per-signal breakdown.

Visit Asan Medical Center →Read the rubricGet your match
11-signal breakdown
  • COA on every lot
    90
  • Cold-chain verified
    JCI + AGS internal QA framework
    95
  • Rx legality (MFDS)
    Wegovy MFDS-approved Apr 2023
    95
  • Compound identity
    JCI + AGS, Newsweek World's Best 22nd
    95
  • Dose accuracy
    Newsweek World #3 Endocrinology / Korea #1
    95
  • Endotoxin testing
    80
  • Refund posture
    65
  • Channel clarity
    2,432 beds, dedicated Diabetes Center
    85
  • Support quality
    intl-patient services, EN-fluent
    80
  • Price transparency
    no public GLP-1 menu; consult-led
    55
  • Longitudinal retention
    Endo & Metabolism dept since 1989
    75
Sources we audited against
How we score

The 11-signal rubric is public.

Identity, dose accuracy, COA, cold-chain, Rx legality, compound identity, endotoxin testing, refund posture, channel clarity, support quality, price transparency, longitudinal retention. Each scored 0 to 100. Vendors that fail our floor are silently filtered out — they don't appear in our match flow at all.

If Asan Medical Center wants to dispute or update this score, contact partner@panya.health. Score updates are recorded on this page with a public changelog.

Full methodology →

Want a match for your situation?

Take the 2-minute quiz. We'll match you against this and the other vendors in your region — based on your dose, urgency, and budget.

Take the quiz

We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.